Back to Search
Start Over
"In situ" endografting in the treatment of arterial and graft infections.
- Source :
-
Journal of vascular surgery [J Vasc Surg] 2017 Jun; Vol. 65 (6), pp. 1824-1829. Date of Electronic Publication: 2017 Mar 27. - Publication Year :
- 2017
-
Abstract
- Objective: Endografts (eg, aortic aneurysm device or covered stent) are increasingly being used to temporize or treat arterial and graft infections in inaccessible areas, in patients with compromised anatomy, or in the presence of active bleeding or rupture. This summary examines the evidence for "in situ" endografting in the treatment these conditions.<br />Methods: A two-level search strategy of the literature (MEDLINE, PubMed, Google Scholar, and The Cochrane Library) was performed for relevant articles listed between January 2000 and December 2015. The review was confined to patients with primary and secondary bacterial or viral arterial infections, with or without fistulization and infection of bypass grafts and arteriovenous accesses. For the purposes of this summary, endografts can be considered to be an aortic aneurysm device or a covered stent.<br />Results: There are no societal guidelines. Endografts have been successfully applied to mycotic arterial aneurysms, aortoenteric, aortobronchial, and arterioureteric fistulae, and to anastomotic bleeds secondary to infection. Multiple reports indicate success at the control of hemorrhage in all locations. Short-term outcomes are good, but fatal infection-related complications, especially if antibiotic therapy is halted, are well reported and necessitate a more definitive plan for the long term.<br />Conclusions: Stent grafts remain an important and viable option for the treatment of mycotic aneurysms, aortoesophageal and aortobronchial fistulae, and infected pseudoaneurysms in anatomically or technically inaccessible locations. In patients with a short life span (<6 months), no further intervention is generally required. In patients with a predicted life span >6 months, careful consideration should be given to a more definitive procedure. Life-long appropriate antibiotic therapy is strongly recommended for any patient receiving an endograft in an infected field.<br /> (Copyright © 2017 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.)
- Subjects :
- Aneurysm, False diagnostic imaging
Aneurysm, False microbiology
Aneurysm, Infected diagnostic imaging
Aneurysm, Infected microbiology
Anti-Bacterial Agents administration & dosage
Arteries diagnostic imaging
Arteries microbiology
Computed Tomography Angiography
Humans
Prosthesis Design
Prosthesis-Related Infections diagnostic imaging
Prosthesis-Related Infections microbiology
Reoperation
Risk Factors
Treatment Outcome
Aneurysm, False surgery
Aneurysm, Infected surgery
Arteries surgery
Blood Vessel Prosthesis adverse effects
Blood Vessel Prosthesis Implantation adverse effects
Blood Vessel Prosthesis Implantation instrumentation
Prosthesis-Related Infections surgery
Stents
Subjects
Details
- Language :
- English
- ISSN :
- 1097-6809
- Volume :
- 65
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- Journal of vascular surgery
- Publication Type :
- Academic Journal
- Accession number :
- 28359717
- Full Text :
- https://doi.org/10.1016/j.jvs.2016.12.134